Concentration responses of RO 20-1724 determined in the PDE4 cell line... | Download Scientific Diagram
Phosphodiesterase 4 Inhibition Impairs Cocaine-Induced Inhibitory Synaptic Plasticity and Conditioned Place Preference | Neuropsychopharmacology
Characterization of the cyclic nucleotide phosphodiesterase subtypes involved in the regulation of the L‐type Ca2+ current in rat ventricular myocytes - Verde - 1999 - British Journal of Pharmacology - Wiley Online Library
Phosphodiesterase Inhibition by Ro 20-1724 Reduces Hyper-IgE Synthesis by Atopic Dermatitis Cells In Vitro
Phosphodiesterase 4 Inhibition Impairs Cocaine-Induced Inhibitory Synaptic Plasticity and Conditioned Place Preference | Neuropsychopharmacology
Ro 20-1724 | CAS 29925-17-5 | SCBT - Santa Cruz Biotechnology
![29925-17-5 | Ro 20-1724 | 4-(3-Butoxy-4-methoxybenzyl)imidazolidin-2-one; 4-[(3-Butoxy-4-methoxyphenyl)methyl]-2-imidazolidinone; 4-(3-Butoxy-4-methoxy benzyl)-2-imidazolidinone; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidone; DL-4-(3-Butoxy-4 ...](https://www.trc-canada.com/prod-img/R700903.png "29925-17-5 | Ro 20-1724 | 4-(3-Butoxy-4-methoxybenzyl)imidazolidin-2-one; 4-[(3-Butoxy-4-methoxyphenyl)methyl]-2-imidazolidinone; 4-(3-Butoxy-4-methoxy benzyl)-2-imidazolidinone; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidone; DL-4-(3-Butoxy-4 ...")
29925-17-5 | Ro 20-1724 | 4-(3-Butoxy-4-methoxybenzyl)imidazolidin-2-one; 4-[(3-Butoxy-4-methoxyphenyl)methyl]-2-imidazolidinone; 4-(3-Butoxy-4-methoxy benzyl)-2-imidazolidinone; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidone; DL-4-(3-Butoxy-4 ...
Ro 20-1724 (4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone, CAS Number: 29925-17-5) | Cayman Chemical
Ro 20-1724 | Cas# 29925-17-5 - GlpBio
Phosphodiesterase Inhibition by Ro 20-1724 Reduces Hyper-IgE Synthesis by Atopic Dermatitis Cells In Vitro
Characterization of the cyclic nucleotide phosphodiesterase subtypes involved in the regulation of the L-type Ca2+ current in rat ventricular myocytes. - Abstract - Europe PMC
![Displacement of [3H]-rolipram by rolipram, Ro 20-1724, and hesperetin... | Download Scientific Diagram](https://www.researchgate.net/publication/221979608/figure/fig6/AS:328455725043729@1455321355959/Displacement-of-3H-rolipram-by-rolipram-Ro-20-1724-and-hesperetin-in-high-affinity.png "Displacement of [3H]-rolipram by rolipram, Ro 20-1724, and hesperetin... | Download Scientific Diagram")
Displacement of [3H]-rolipram by rolipram, Ro 20-1724, and hesperetin... | Download Scientific Diagram
Ro 20-1724 (CAS 29925-17-5): R&D Systems
Ro 20-1724, Tocris Bioscience, Quantity: 50mg | Fisher Scientific
Ro-20-1724 - CAS 29925-17-5 - Calbiochem A cell-permeable, selective inhibitor of cAMP-specific phosphodiesterase (PDE IV; IC = 2 uM). 29925-17-5
RO 20-1724, cAMP-specific Phosphodiesterase Inhibitor biochemical
Ro 20-1724 | 29925-17-5 | Buy Ro 20-1724 from Supplier EMMX™
RO 20-1724 Supplier | CAS 29925-17-5 | Focus Biomolecules
RO 20-1724, Phosphodiesterase 4 (PDE4) inhibitor (CAS 29925-17-5) (ab141492)
Effect of PKA inhibitors on rolipram, Ro-20-1724 and forskolin induced... | Download Scientific Diagram
Ro 20-1724 (4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone, CAS Number: 29925-17-5) | Cayman Chemical
Synergistic Inhibition of Vascular Smooth Muscle Cell Migration by Phosphodiesterase 3 and Phosphodiesterase 4 Inhibitors | Circulation Research
Ro 20-1724 | ≥99%(HPLC) | Selleck | PDE 阻害剤
Ro 20-1724 | CAS 29925-17-5 | PDE4 inhibitor
